510(k) · Cleared
ClearedAVIEW
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Coreline Soft Co., Ltd. · LLZ System, Image Processing, Radiological
Cleared on Aug 26, 2020 as substantially equivalent to K171199 (Coreline Soft Co., Ltd., 2018) after a 161-day review. Its family tree reaches back 9 generations to 1995. 5 later devices descend from it.
- Decided
- Aug 26, 2020
- Review
- 161 days
- Class
- Class II
- Product code
- LLZ
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 9 generations to K954355 (1995). 13 ancestors in all. 5 later devices descend from it, 1 citing it directly.
- Root · 9 generations backK954355 Advantage Windows 3D with Navigator OptionGeneral Electric Co. · 1995
- 5 generations between
- 3 generations backK083227 Vida Pulmonary Workstation 2 (PW2)Vida Diagnostics, Inc. · 2008
- 2 generations backK151919 Vitrea CT Lung Density Analysis SoftwareVital Images, Inc. · 2015
- 1 generation backK171199 AVIEWCoreline Soft Co., Ltd. · 2018
- This deviceK200714 AVIEWCoreline Soft Co., Ltd. · 2020
- Descendant · cites it directly · 4 of its ownK214036 AVIEWCoreline Soft Co., Ltd. · 2022
- Descendant · 2 generations on · 2 of its ownK233211 Aview CacCoreline Soft Co., Ltd. · 2024
- Descendant · 3 generations on · 0 of its ownK250288 TeraRecon Cardiovascular.Calcification.CTTerarecon,Inc. · 2025
- Descendant · 2 generations on · 0 of its ownK243689 AVIEWCoreline Soft Co., Ltd. · 2025
- Descendant · 3 generations on · 0 of its ownK243696 Aview CacCoreline Soft Co., Ltd. · 2025
Show all 9 generations
- Root · 9 generations backK954355 Advantage Windows 3D with Navigator OptionGeneral Electric Co. · 1995
- 8 generations backK974715 Advantage 3D XRGE Medical Systems · 1998
- 7 generations backK984634 3D-AngioSiemens Medical Corp. · 1999
- 6 generations backK011447 IN Space 3DSiemens Medical Solutions USA, Inc. · 2001
- 5 generations backK043469 Syngo Inspace 4DSiemens AG Medical Solutions · 2005
- 4 generations backK071513 Inspace 4D Software Package with Extended FunctionalitySiemens Medical Solutions · 2007
- 3 generations backK083227 Vida Pulmonary Workstation 2 (PW2)Vida Diagnostics, Inc. · 2008
- 2 generations backK151919 Vitrea CT Lung Density Analysis SoftwareVital Images, Inc. · 2015
- 1 generation backK171199 AVIEWCoreline Soft Co., Ltd. · 2018
- This deviceK200714 AVIEWCoreline Soft Co., Ltd. · 2020
Most influential descendants
Showing 5 of 5 · See all- K214036AVIEWCoreline Soft Co., Ltd. · 2022 · cites it directly4descendants
- K233211Aview CacCoreline Soft Co., Ltd. · 2024 · 2 generations on2descendants
- K250288TeraRecon Cardiovascular.Calcification.CTTerarecon,Inc. · 2025 · 3 generations on0descendants
- K243689AVIEWCoreline Soft Co., Ltd. · 2025 · 2 generations on0descendants
- K243696Aview CacCoreline Soft Co., Ltd. · 2025 · 3 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −9 | K954355 | Advantage Windows 3D with Navigator Option | General Electric Co. | 1995 | — |
| −8 | K974715 | Advantage 3D XR | GE Medical Systems | 1998 | — |
| −7 | K984634 | 3D-Angio | Siemens Medical Corp. | 1999 | — |
| −6 | K011447 | IN Space 3D | Siemens Medical Solutions USA, Inc. | 2001 | — |
| −5 | K043469 | Syngo Inspace 4D | Siemens AG Medical Solutions | 2005 | — |
| −4 | K071513 | Inspace 4D Software Package with Extended Functionality | Siemens Medical Solutions | 2007 | — |
| −3 | K083227 | Vida Pulmonary Workstation 2 (PW2) | Vida Diagnostics, Inc. | 2008 | — |
| −2 | K151919 | Vitrea CT Lung Density Analysis Software | Vital Images, Inc. | 2015 | — |
| −1 | K171199 | AVIEW | Coreline Soft Co., Ltd. | 2018 | — |
| 0 (this device) | K200714 | AVIEW | Coreline Soft Co., Ltd. | 2020 | — |
| +1 | K214036 | AVIEW | Coreline Soft Co., Ltd. | 2022 | — |
| +2 | K233211 | Aview Cac | Coreline Soft Co., Ltd. | 2024 | — |
| +3 | K250288 | TeraRecon Cardiovascular.Calcification.CT | Terarecon,Inc. | 2025 | — |
| +2 | K243689 | AVIEW | Coreline Soft Co., Ltd. | 2025 | — |
| +3 | K243696 | Aview Cac | Coreline Soft Co., Ltd. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
| 1998 | 2 | 0 |
| 2000 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2022 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LLZ device
- #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K171199 | AVIEWSummary page 5…ification Name: System, image processing, radiological (21CFR 892.2050) Regulatory Class: II Product Code: LLZ, JAK 3 PREDICATE DEVICE AVIEW by Coraline Soft Co., Ltd. (K171199) Name of Device: AVIEW Common or Usual Name: Image Processing Software Classification Name: System, image processing, radiologic… | 2018 |
| † | K141069 | Lung Density Analysis | 2014 |
| † | K193220 | Aview LCS | 2020 |
| † | K183268 | AI-Rad Companion (Cardiovascular) | 2019 |
| † | K990426 | Calcium Scoring | 1999 |
| † | K043617 | Imagechecker CT Cad Software System | 2007 |
What descends from it? (5)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K214036 | AVIEW | 2022 | 4 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 25 years and passes through 9 companies; a new generation was cleared every 2.4 years on median.
- 1 of the 13 ancestors has a recall of any class.
- Of its descendants, K214036 (Coreline Soft Co., Ltd., 2022) has gone furthest, with 4 descendants of its own.
How does its category compare?
All LLZ devicesLLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.
FDA decisions per year · LLZ
58in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LLZ
173in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LLZ
11in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LLZ
116in 2025
MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 76 | 36 | 20 | 152 |
| 2008 | 94 | 52 | 32 | 154 |
| 2009 | 70 | 62 | 21 | 145 |
| 2010 | 51 | 98 | 17 | 145 |
| 2011 | 106 | 79 | 30 | 454 |
| 2012 | 82 | 87 | 12 | 266 |
| 2013 | 95 | 84 | 64 | 1,130 |
| 2014 | 78 | 89 | 6 | 15,631 |
| 2015 | 64 | 90 | 16 | 211 |
| 2016 | 82 | 90 | 12 | 290 |
| 2017 | 78 | 107 | 5 | 104 |
| 2018 | 104 | 105 | 7 | 72 |
| 2019 | 74 | 107 | 2 | 88 |
| 2020 | 81 | 115 | 6 | 82 |
| 2021 | 83 | 116 | 3 | 70 |
| 2022 | 65 | 137 | 4 | 28 |
| 2023 | 87 | 157 | 8 | 26 |
| 2024 | 62 | 131 | 6 | 42 |
| 2025 | 58 | 173 | 11 | 116 |
| 2026 | 45 | 110 | 14 | — |
What is it indicated for?
AVIEW provides CT values for pulmonary tissue from CT thoracic and cardiac datasets. This software could be used to support the physician quantitatively in the diagnosis, follow up evaluation and documentation of CT lung tissue images by providing image segmentation of sub-structures in lung, lobe, airways and cardiac, registration of inspiration and expiration which could analyze quantitative information such as air trapping volume, air trapped index…
Read the full statement (329 words)
AVIEW provides CT values for pulmonary tissue from CT thoracic and cardiac datasets. This software could be used to support the physician quantitatively in the diagnosis, follow up evaluation and documentation of CT lung tissue images by providing image segmentation of sub-structures in lung, lobe, airways and cardiac, registration of inspiration and expiration which could analyze quantitative information such as air trapping volume, air trapped index, and inspiration/expiration ratio. And also, volumetric and structure analysis, density evaluation and reporting tools. AVIEW is also used to store, transfer, inquire and display CT data set on premise and as cloud environment as well to allow users to connect by various environment such as mobile devices and chrome browser. Characterizing nodules in the lung in a single study, or over the time course of several thoracic studies. Characterizations include nodule type, location of the nodule and measurements such as size (major axis, minor axis), estimated effective diameter from the volume of the nodule, volume of the nodule, Mean HU(the average value of the CT pixel inside the nodule in HU), Minimum HU, Max HU, mass(mass calculated from the CT pixel value), and volumetric measures(Solid major; length of the longest diameter measured in 3D for solid portion of the nodule, Solid 2nd Major: The length of the longest diameter of the solid part, measured in sections perpendicular to the Major axis of the solid portion of the nodule), VDT (Volume doubling time), and Lung-RADS (classification proposed to aid with findings). The system automatically performs the measurement, allowing lung nodules and measurements to be displayed and, integrate with FDA certified Mevis CAD (Computer aided detection) (K043617). It also provides CAC analysis by segmentation of four main artery (right coronary artery, left main coronary, left anterior descending and left circumflex artery then extracts calcium on coronary artery to provide Agatston score, volume score and mass score by whole and each segmented artery type. Based on the score, provides CAC risk based on age and gender.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K200714 · printed Nov 6, 2026
Cite this page
510(k) Report. “K200714: AVIEW.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K200714
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026